Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 8-K Event Executive or director change
  4. 8-K Event Shareholder vote results
  5. SC 13G/A Stake Amended Statement of Ownership
  6. 8-K/A Event Exhibits
  7. DEFA14A Proxy Proxy Materials
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 8-K Event Material agreement · Agreement ended · New debt or obligation
  11. ARS Other Annual Report to Security Holders
  12. DEFA14A Proxy Proxy Materials
  13. DEF 14A Proxy Proxy Statement
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 10-K Report Annual Report
  16. 8-K Event Results of operations
  17. 8-K Event Acquisition or sale completed · Debt accelerated · Other events
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 8-K Event Executive or director change

Page 8 of 47 · 923 filings